Johnson & Johnson (NYSE:JNJ)
| 158.33 Delayed Data As of Jun 05 |  +0.01 / +0.01%Today’s Change | 150.11 Today|||52-Week Range 183.35 | -10.37% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 158.32 |
| Today’s open | 156.97 |
| Day’s range | 156.43 - 158.65 |
| Volume | 4,502 |
| Average volume (3 months) | 7,752,785 |
| Market cap | $407.9B |
Data as of 4:00pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | -13.84% |
| Earnings growth (this year) | +4.91% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 32.9 |
| Price/Sales | 4.95 |
| Price/Book | 5.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +0.08 | +0.02% |
| MRKMerck | +0.01 | +0.01% |
| NVONovo Nordisk | +0.05 | +0.03% |
| ABBVAbbVie | +0.01 | +0.01% |
Data as of 4:00pm ET, 06/05/2023
Financials
| Next reporting date | July 20, 2023 |
| EPS forecast (this quarter) | $2.62 |
| Annual revenue (last year) | $95.0B |
| Annual profit (last year) | $17.9B |
| Net profit margin | 18.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
